HIV drug kickbacks: Gilead Sciences to pay USD 202 million to settle lawsuit Ruchika Sharma1 May 2025 3:15 PM ISTNew York: Gilead Sciences has agreed to pay USD 202 million to settle a whistleblower lawsuit that accused the company of engaging in civil fraud...
USFDA approves Biktarvy label update with data for pregnant adults with HIV: Gilead Sciences Ruchika Sharma28 April 2024 11:30 AM ISTFoster City: Gilead Sciences, Inc. has announced the U.S. Food and Drug Administration (FDA) has approved an updated label with additional data...
Expanded Indication for Gilead Biktarvy for HIV with suppressed viral loads, pre-existing resistance gets USFDA okay Ruchika Sharma27 Feb 2024 12:30 PM ISTFoster City: Gilead Sciences, Inc. has announced the U.S. Food and Drug Administration (FDA) has approved a new, expanded indication for Biktarvy...
GSK to get USD 1.25 billion from Gilead Sciences to settle dispute of HIV based drug unit Ruchika Sharma3 Feb 2022 2:44 PM ISTGilead will also pay a 3 percent royalty until 2027 on sales of Biktarvy and on future US sales of any product containing its main component.
Gilead Biktarvy expanded indication for HIV-1 treatment in pediatrics gets USFDA okay Ruchika Sharma20 Oct 2021 2:32 PM ISTFoster City: Gilead Sciences, Inc. has announced that the U.S. Food and Drug Administration (USFDA) has approved a new low-dose tablet dosage form of...
